Charles Schwab’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,373
| Closed | -$20.6K | – | 3661 |
|
2024
Q1 | $20.6K | Hold |
4,373
| – | – | ﹤0.01% | 3434 |
|
2023
Q4 | $20.1K | Hold |
4,373
| – | – | ﹤0.01% | 3485 |
|
2023
Q3 | $11.4K | Hold |
4,373
| – | – | ﹤0.01% | 3556 |
|
2023
Q2 | $21.1K | Hold |
4,373
| – | – | ﹤0.01% | 3552 |
|
2023
Q1 | $28.8K | Hold |
4,373
| – | – | ﹤0.01% | 3456 |
|
2022
Q4 | $48.5K | Buy |
+4,373
| New | +$48.5K | ﹤0.01% | 3365 |
|
2022
Q2 | – | Sell |
-1,200
| Closed | -$30K | – | 3612 |
|
2022
Q1 | $30K | Hold |
1,200
| – | – | ﹤0.01% | 3568 |
|
2021
Q4 | $58K | Buy |
+1,200
| New | +$58K | ﹤0.01% | 3498 |
|